Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
32 hedge funds and large institutions have $8.08M invested in Fibrocell Science Inc. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
0% more funds holding
Funds holding: 32 → 32 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
67% less capital invested
Capital invested by funds: $24.2M → $8.08M (-$16.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$4.77M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.97M |
| 3 |
AC
Armistice Capital
New York
|
+$1.07M |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$783K |
| 5 |
FPF
FNY Partners Fund
New York
|
+$350K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.8M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$148K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$107K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$52K |
| 5 |
CCA
Conservest Capital Advisors
Wynnewood,
Pennsylvania
|
-$51K |
FCSC Hedge Fund Activity: Q4 2017 in Review
32 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2017, worth a combined $8.08M — down 67% from $24.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new FCSC positions and 7 closed out — a net gain of 1 holder — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Third Security, adding an estimated $4.77M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.8M sold.
- 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $8.08M of Fibrocell Science Inc. stock for Q4 2017, down 67% quarter-over-quarter.
- 8 funds opened new Fibrocell Science Inc. positions in Q4 2017 and 7 closed out, a net change of +1 holder.
- The largest Fibrocell Science Inc. buyer in Q4 2017 was Third Security, an estimated $4.77M added.
- The largest Fibrocell Science Inc. seller in Q4 2017 was Fidelity Investments, an estimated $1.8M sold.
Based on aggregated 13F filings for Q4 2017.